搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
6 天
Tourmaline Bio第四季度亏损扩大 股价下跌
纽约 - 临床阶段生物科技公司Tourmaline Bio, Inc. (NASDAQ: TRML )周三报告称,由于研发支出增加,第四季度亏损扩大。财报发布后,公司股价下跌2%。 2024年第四季度,公司净亏损为2,220万美元,每股亏损0.86美元,而去年同期亏损1,290万美元,每股亏损0.81美元。
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Fed holds rates steady
Minnesota senator charged
FBI agent arrested
Alaska plane crash report
World’s happiest countries
Confirms marriage to Good
Former F1 team owner dies
Sia files for divorce
Makes NBA history
Pentagon restores webpage
Standoff ends outside HQ
Accuses parent company
Sentenced for fraud
To join AI data center fund
Amtrak CEO steps down
Trump meets oil executives
Israeli strikes across Gaza
Global music revenues rise
$524M for Helene recovery
Found guilty in fraud trial
Lead investigator fired
Retires after 29 years
SEC drops Ripple case
$175M in funding paused
Ex-studio engineer charged
WV couple sentenced
Files new bankruptcy plan
Jury finds Greenpeace liable
Propose banning 'tush push'
Issues dengue fever warning
In-person identity checks
Ford recall
反馈